Microplate Dx Limited

medical devices

About

Microplate Dx Limited is a diagnostics company based in Glasgow, Scotland, focused on rapid antibiotic susceptibility testing (AST) to address antimicrobial resistance (AMR). Founded in August 2021, the company specializes in developing innovative solutions for urinary tract infections (UTIs). Their core product, the patented *RapidPlate* technology, delivers results with 96% accuracy in just 30 minutes, enabling healthcare providers to quickly identify the most effective antibiotic treatments. The company combines advanced hardware with sophisticated software algorithms to provide reliable AST results. Microplate Dx aims to improve clinical outcomes by ensuring patients receive the correct antibiotic promptly, thereby supporting antimicrobial stewardship efforts. With a multidisciplinary team and recent funding of £2.5 million, Microplate Dx is committed to advancing its technology and making a significant impact in the field of diagnostics.

Technologies

Outlook Amazon AWS Mobile Friendly Vimeo Data Analytics Remote AI IoT

Keywords

medical equipment manufacturing rapid antibiotic susceptibility testing biotechnology bacterial infection testing biosensor electrodes b2b clinical diagnostics research and development in the physical engineering and life sciences healthcare innovation life sciences infection control urinary tract infections medical diagnostics healthcare diagnostics medical devices data algorithms infection diagnosis impedance-based biosensors antibiotic susceptibility detection microbial detection data processing algorithms healthcare antimicrobial stewardship services biosensors rapidplate technology healthtech microbial resistance detection

Location

106 Rottenrow, Scotland, United Kingdom, G4 0NW

Related Companies

Companies in the same industry